The incidence rate of Nasopharyngeal Carcinoma (NPC) is remarkably high among Southeast Asia and Southern China regions, particularly Hong Kong. Therefore, it is also known as "Canton Tumor". Nasopharyngeal Carcinoma (NPC) does not have significant symptoms at preliminary stage, most of the patients would not be aware of the illness and have missed the optimal treatment period. In the early stage of Nasopharyngeal cancer, there are some similar symptoms with common cold, such as nose bleeding, headache, tinnitus, stuffiness, hearing loss, hoarseness and etc. It is reported that approximately 80% of the unscreened patients are in the advanced stage when the illness is diagnosed. There is no vaccine available against NPC at the moment, thus early screening will be the most effective means to raise early awareness, which could also increase the cure rate and survival rate.